Novel PD-1 inhibitor prolgolimab: expanding non-resectable/metastatic melanoma therapy choice
S. Tjulandin(Ministry of Health of the Russian Federation), Lev Demidov(Ministry of Health of the Russian Federation), Vladimir Moiseyenko(State Budget Institution of Health St. Petersburg Clinical Research Center Specialized Types of Medical Care), Светлана Проценко(Institute of Oncology NN Petrov), Т. Yu. Semiglazova(Institute of Oncology NN Petrov), Svetlana Odintsova, Р. А. Зуков(Krasnoyarsk Regional Clinical Hospital), Sergey Lazarev, Yuliya Makarova(Ministry of Health of the Russian Federation), Marina Nechaeva, Dina Sakaeva, Aleksey Andreev(Federal Medical-Biological Agency), Anna Tarasova(Samara Regional Clinical Oncology Center), Natalya Fadeyeva(Chelyabinsk Regional Clinical Oncology Center), Mariia Shustova(BIOCAD (Russia)), Ivan V. Kuryshev(BIOCAD (Russia))
Cited by 63
Abstract
Related Papers
No related papers found
Powered by citation graph analysis